Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Equity Average: 2020-2024

Historic Equity Average for Eton Pharmaceuticals (ETON) over the last 5 years, with Dec 2024 value amounting to $20.0 million.

  • Eton Pharmaceuticals' Equity Average rose 59.93% to $23.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.5 million, marking a year-over-year increase of 59.93%. This contributed to the annual value of $20.0 million for FY2024, which is 39.75% up from last year.
  • According to the latest figures from FY2024, Eton Pharmaceuticals' Equity Average is $20.0 million, which was up 39.75% from $14.3 million recorded in FY2023.
  • In the past 5 years, Eton Pharmaceuticals' Equity Average ranged from a high of $20.0 million in FY2024 and a low of $13.1 million during FY2020.
  • Moreover, its 3-year median value for Equity Average was $15.4 million (2022), whereas its average is $16.5 million.
  • In the last 5 years, Eton Pharmaceuticals' Equity Average dropped by 7.76% in 2022 and then spiked by 39.75% in 2024.
  • Over the past 5 years, Eton Pharmaceuticals' Equity Average (Yearly) stood at $13.1 million in 2020, then grew by 27.01% to $16.6 million in 2021, then declined by 7.76% to $15.4 million in 2022, then fell by 7.01% to $14.3 million in 2023, then surged by 39.75% to $20.0 million in 2024.